samuel.croset@sumitovant.com
OME alert: Eotaxin (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
samuel.croset@sumitovant.com
OME alert: Interleukin-33 (2020-07-20)
   email replied
samuel.croset@sumitovant.com
OME alert: Autoimmune disease (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
samuel.croset@sumitovant.com
OME alert: anti-FcRn (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Multiple Sclerosis (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: alzheimer (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: JAK-STAT (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Roivant (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
yoann.randriamihaja@sumitovant.com
OME alert: United therapeutics (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
yoann.randriamihaja@sumitovant.com
OME alert: Positive clinical trial results (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
yoann.randriamihaja@sumitovant.com
OME alert: dry eye (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
yoann.randriamihaja@sumitovant.com
OME alert: melatonin (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: bridgebio (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Cystic Fibrosis & Gene Therapy Sam A (Cooccurence) (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Women's Health - Sam (standard) (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Prostate Cancer - Sam A (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Women's Health - Sam A (cooccurence) (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: Urology Sam A (Cooccurence) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
yoann.randriamihaja@sumitovant.com
OME alert: PAH - Sam A (Standard) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
yoann.randriamihaja@sumitovant.com
OME alert: AAV and purification (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: AAV (2020-07-20)
   email replied
yoann.randriamihaja@sumitovant.com
OME alert: AAV and production (2020-07-20)
   email replied
jon.kluft@roivant.com
OME alert: Drugs (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
jon.kluft@roivant.com
OME alert: anti-FcRn (2020-07-20)
   email replied
bill.mcmahon@sumitovant.com
OME alert: Roivant (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
bill.mcmahon@sumitovant.com
OME alert: Alzheimer (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
bill.mcmahon@sumitovant.com
OME alert: Positive clinical trial results (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
bill.mcmahon@sumitovant.com
OME alert: Women's Health - Sam (standard) (2020-07-20)
   email replied
bill.mcmahon@sumitovant.com
OME alert: Prostate Cancer - Sam A (2020-07-20)
   email replied
bill.mcmahon@sumitovant.com
OME alert: Women's Health - Sam A (cooccurence) (2020-07-20)
   email replied
bill.mcmahon@sumitovant.com
OME alert: Urology Sam A (Cooccurence) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
bill.mcmahon@sumitovant.com
OME alert: PAH - Sam A (Standard) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
bill.mcmahon@sumitovant.com
OME alert: AAV and purification (2020-07-20)
   email replied
bill.mcmahon@sumitovant.com
OME alert: AAV (2020-07-20)
   email replied
bill.mcmahon@sumitovant.com
OME alert: AAV and production (2020-07-20)
   email replied
justin.dimartino@sumitovant.com
OME alert: anti-FcRn (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
julia.gray@sumitovant.com
OME alert: Venture Capital (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
julia.gray@sumitovant.com
OME alert: Positive clinical trial results (2020-07-20)
   email replied
julia.gray@sumitovant.com
OME alert: AI Drug Discovery (2020-07-20)
   email replied
julia.gray@sumitovant.com
OME alert: Prostate Cancer - Sam A (2020-07-20)
   email replied
mayukh@roivant.com
OME alert: Myovant (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
isabel.metzger@sumitovant.com
OME alert: fentanyl (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
isabel.metzger@sumitovant.com
OME alert: anti-FcRn (2020-07-20)
   email replied
isabel.metzger@sumitovant.com
OME alert: Drugs (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
isabel.metzger@sumitovant.com
OME alert: Positive clinical trial results (2020-07-20)
   email replied
isabel.metzger@sumitovant.com
OME alert: Cystic Fibrosis & Gene Therapy Sam A (Cooccurence) (2020-07-20)
   email replied
isabel.metzger@sumitovant.com
OME alert: Women's Health - Sam (standard) (2020-07-20)
   email replied
isabel.metzger@sumitovant.com
OME alert: Prostate Cancer - Sam A (2020-07-20)
   email replied
isabel.metzger@sumitovant.com
OME alert: Women's Health - Sam A (cooccurence) (2020-07-20)
   email replied
isabel.metzger@sumitovant.com
OME alert: Urology Sam A (Cooccurence) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
isabel.metzger@sumitovant.com
OME alert: PAH - Sam A (Standard) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
houston.warren@sumitovant.com
OME alert: xiidra (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
cody.schiffer@sumitovant.com
OME alert: Multiple Sclerosis (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
cody.schiffer@sumitovant.com
OME alert: Women's Health - Sam (standard) (2020-07-20)
   email replied
cody.schiffer@sumitovant.com
OME alert: Prostate Cancer - Sam A (2020-07-20)
   email replied
cody.schiffer@sumitovant.com
OME alert: Women's Health - Sam A (cooccurence) (2020-07-20)
   email replied
cody.schiffer@sumitovant.com
OME alert: Urology Sam A (Cooccurence) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
cody.schiffer@sumitovant.com
OME alert: PAH - Sam A (Standard) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
cody.schiffer@sumitovant.com
OME alert: Cystic Fibrosis & Gene Therapy Sam A (Cooccurence) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
cody.schiffer@sumitovant.com
OME alert: DK-Protein Degrader Alert: Companies (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
ryan.costa@roivant.com
OME alert: Bluebird Alert (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
archit.sheth-shah@roivant.com
OME alert: Vaccines general (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
archit.sheth-shah@roivant.com
OME alert: Protein Degrader Alert: Companies (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
emir.haskovic@roivant.com
OME alert: endometriosis (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
anthony.bogachev@roivant.com
OME alert: CF GT (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
anthony.bogachev@roivant.com
OME alert: Lung Bio GT Companies (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
simon.lowry@roivant.com
OME alert: GMCSF (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
raheleh.hatami@roivant.com
OME alert: RSV Antivirals (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
raheleh.hatami@roivant.com
OME alert: Polycystic Kidney Disease (2020-07-20)
   email replied
raheleh.hatami@roivant.com
OME alert: Congenital Adrenal Hyperplasia (2020-07-20)
   email replied
raheleh.hatami@roivant.com
OME alert: IgaN assets (2020-07-20)
   email replied
andrew.bogorad@roivant.com
OME alert: Positive clinical trial results (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
jillian.lindsey@roivant.com
OME alert: Positive clinical trial results (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
jonathan.jones@roivant.com
OME alert: Positive clinical trial results (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
sam.azoulay@sumitovant.com
OME alert: Women's Health (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
sam.azoulay@sumitovant.com
OME alert: Urology (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
sam.azoulay@sumitovant.com
OME alert: PAH (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
sam.azoulay@sumitovant.com
OME alert: Cystic Fibrosis & Gene Therapy (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
benjamin.dorner@roivant.com
OME alert: GM-CSF (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
benjamin.dorner@roivant.com
OME alert: GM-CSF Competitors (2020-07-20)
   email replied
benjamin.dorner@roivant.com
OME alert: otilimab (2020-07-20)
   email replied
benjamin.dorner@roivant.com
OME alert: Mavrilimumab (Kiniksa) (2020-07-20)
   email replied
benjamin.dorner@roivant.com
OME alert: lenzilumab (Humanigen) (2020-07-20)
   email replied
benjamin.dorner@roivant.com
OME alert: otilimab (GSK) (2020-07-20)
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
daniel.kwon@roivant.com
OME alert: Protein Degrader Alert: Companies (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
dylan.wile@roivant.com
OME alert: Protein Degrader Alert: Companies (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
[] ---- keywords in empty email
empty email
carson.tao@sumitovant.com
OME alert: Women's Health - Sam A (cooccurence) (2020-07-20)
 > Sign as  [b'LOGIN completed.']
   email replied
carson.tao@sumitovant.com
OME alert: Prostate Cancer - Sam A (2020-07-20)
   email replied
carson.tao@sumitovant.com
OME alert: AAV and purification (2020-07-20)
   email replied
carson.tao@sumitovant.com
OME alert: AAV (2020-07-20)
   email replied
carson.tao@sumitovant.com
OME alert: AAV and production (2020-07-20)
   email replied
cody.schiffer@sumitovant.com
OME Alerts Completion  (2020-07-19)
 > Sign as  [b'LOGIN completed.']
   email replied
cody.schiffer@roivant.com
Search Completion  (2020-07-19)
 > Sign as  [b'LOGIN completed.']
   email replied
yoann.randriamihaja@sumitovant.com
OME Alerts Completion  (2020-07-19)
 > Sign as  [b'LOGIN completed.']
   email replied
ayman.mohammad@roivant.com
Search Completion  (2020-07-19)
 > Sign as  [b'LOGIN completed.']
   email replied
andrew.bogorad@roivant.com
Search Completion  (2020-07-19)
 > Sign as  [b'LOGIN completed.']
   email replied
done
second debug
